Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Body mass index in young men and risk of inflammatory bowel disease through adult life: A population-based Danish cohort study.

Mendall MA, Jensen CB, Sørensen TIA, Ängquist LH, Jess T.

Sci Rep. 2019 Apr 23;9(1):6360. doi: 10.1038/s41598-019-42642-8.

2.

Childhood body mass index and risk of inflammatory bowel disease in adulthood: a population-based cohort study.

Jensen CB, Ängquist LH, Mendall MA, Sørensen TIA, Baker JL, Jess T.

Am J Gastroenterol. 2018 May;113(5):694-701. doi: 10.1038/s41395-018-0031-x. Epub 2018 Mar 13.

PMID:
29535417
3.
4.

Treatment of Crohn's Disease with an IgG4-Guided Exclusion Diet: A Randomized Controlled Trial.

Gunasekeera V, Mendall MA, Chan D, Kumar D.

Dig Dis Sci. 2016 Apr;61(4):1148-57. doi: 10.1007/s10620-015-3987-z. Epub 2016 Jan 25.

PMID:
26809868
5.

Diverticular Disease and Vascular Diseases: A Shared Responsiveness to Injury Is Likely to Be the Underlying Mechanism.

Mendall MA.

Clin Gastroenterol Hepatol. 2015 Jul;13(7):1375. doi: 10.1016/j.cgh.2014.12.004. Epub 2014 Dec 10. No abstract available.

PMID:
25499509
6.

Environment and risk of Crohn's disease: comments on "the increasing weight of Crohn's disease subjects in clinical trials".

Mendall MA.

Inflamm Bowel Dis. 2014 Apr;20(4):E11-2. doi: 10.1097/MIB.0000000000000005. No abstract available.

PMID:
24562176
7.

Advanced age influences the dynamic changes in circulating C-reactive protein following injury.

Pinato DJ, Bains J, Irkulla S, Pomroy J, Ujam B, Gaze D, Mendall MA.

J Clin Pathol. 2013 Aug;66(8):695-9. doi: 10.1136/jclinpath-2012-201374. Epub 2013 Mar 28.

PMID:
23539737
8.

Abdominal adiposity is the main determinant of the C-reactive response to injury in subjects undergoing inguinal hernia repair.

Irkulla S, Ujam B, Gaze D, Kumar D, Mendall MA.

J Inflamm (Lond). 2013 Feb 7;10(1):5. doi: 10.1186/1476-9255-10-5.

9.

Ethnicity in relation to incidence of oesophageal and gastric cancer in England.

Coupland VH, Lagergren J, Konfortion J, Allum W, Mendall MA, Hardwick RH, Linklater KM, Møller H, Jack RH.

Br J Cancer. 2012 Nov 20;107(11):1908-14. doi: 10.1038/bjc.2012.465. Epub 2012 Oct 11.

10.

Incidence and survival of oesophageal and gastric cancer in England between 1998 and 2007, a population-based study.

Coupland VH, Allum W, Blazeby JM, Mendall MA, Hardwick RH, Linklater KM, Møller H, Davies EA.

BMC Cancer. 2012 Jan 12;12:11. doi: 10.1186/1471-2407-12-11.

11.

Is obesity a risk factor for Crohn's disease?

Mendall MA, Gunasekera AV, John BJ, Kumar D.

Dig Dis Sci. 2011 Mar;56(3):837-44. doi: 10.1007/s10620-010-1541-6. Epub 2011 Jan 8.

PMID:
21221790
12.

Do guidelines improve clinical practice? - a national survey on surveillance colonoscopies.

John BJ, Irukulla S, Mendall MA, Abulafi AM.

Colorectal Dis. 2010 Jul;12(7):642-5. doi: 10.1111/j.1463-1318.2009.01869.x. Epub 2009 Apr 10.

PMID:
19486096
13.

Chronic subclinical bowel inflammation may explain increased risk of colorectal cancer in obese people.

John BJ, Abulafi AM, Poullis A, Mendall MA.

Gut. 2007 Jul;56(7):1034-5. No abstract available.

14.

Systematic review: adipose tissue, obesity and gastrointestinal diseases.

John BJ, Irukulla S, Abulafi AM, Kumar D, Mendall MA.

Aliment Pharmacol Ther. 2006 Jun 1;23(11):1511-23. Review.

15.

Bowel inflammation as measured by fecal calprotectin: a link between lifestyle factors and colorectal cancer risk.

Poullis A, Foster R, Shetty A, Fagerhol MK, Mendall MA.

Cancer Epidemiol Biomarkers Prev. 2004 Feb;13(2):279-84.

16.

Effect of the CD14 promoter polymorphism on liver function tests and its association with alcohol and obesity.

Poullis AP, Shetty AK, Risley PD, Collinson PO, Mendall MA.

Eur J Gastroenterol Hepatol. 2003 Dec;15(12):1317-22.

PMID:
14624155
17.

Emerging role of calprotectin in gastroenterology.

Poullis A, Foster R, Mendall MA, Fagerhol MK.

J Gastroenterol Hepatol. 2003 Jul;18(7):756-62. Review.

PMID:
12795745
18.

Proton pump inhibitors are associated with elevation of faecal calprotectin and may affect specificity.

Poullis A, Foster R, Mendall MA, Shreeve D, Wiener K.

Eur J Gastroenterol Hepatol. 2003 May;15(5):573-4; author reply 574. No abstract available.

PMID:
12702920
19.

Increased risk of atherosclerosis is confined to CagA-positive Helicobacter pylori strains: prospective results from the Bruneck study.

Mayr M, Kiechl S, Mendall MA, Willeit J, Wick G, Xu Q.

Stroke. 2003 Mar;34(3):610-5. Epub 2003 Feb 13.

PMID:
12624280
21.

C-reactive protein and carotid intimal medial thickness in a community population.

Sitzer M, Markus HS, Mendall MA, Liehr R, Knorr U, Steinmetz H.

J Cardiovasc Risk. 2002 Apr;9(2):97-103.

PMID:
12006917
22.

Helicobacter pylori infection, the cytotoxin gene A strain, and carotid artery intima-media thickness.

Markus HS, Risley P, Mendall MA, Steinmetz H, Sitzer M.

J Cardiovasc Risk. 2002 Feb;9(1):1-6.

PMID:
11984211
23.

A new, highly sensitive assay for C-reactive protein can aid the differentiation of inflammatory bowel disorders from constipation- and diarrhoea-predominant functional bowel disorders.

Poullis AP, Zar S, Sundaram KK, Moodie SJ, Risley P, Theodossi A, Mendall MA.

Eur J Gastroenterol Hepatol. 2002 Apr;14(4):409-12.

PMID:
11943955
24.

Review article: faecal markers in the assessment of activity in inflammatory bowel disease.

Poullis A, Foster R, Northfield TC, Mendall MA.

Aliment Pharmacol Ther. 2002 Apr;16(4):675-81. Review.

25.

Antibiotics increase functional abdominal symptoms.

Maxwell PR, Rink E, Kumar D, Mendall MA.

Am J Gastroenterol. 2002 Jan;97(1):104-8.

PMID:
11808932
26.

Ischaemic heart disease and Cag A strains of Helicobacter pylori in the Caerphilly heart disease study.

Stone AF, Risley P, Markus HS, Butland BK, Strachan DP, Elwood PC, Mendall MA.

Heart. 2001 Nov;86(5):506-9.

27.

Alcohol, obesity, and TNF-alpha.

Poullis A, Mendall MA.

Gut. 2001 Aug;49(2):313-4. No abstract available.

28.

Lymphocytic gastritis and Helicobacter pylori: reluctant mucosal partners?

Sundaram KK, Mendall MA.

Helicobacter. 2000 Dec;5(4):248-9. No abstract available.

PMID:
11179991
29.

C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men.

Mendall MA, Strachan DP, Butland BK, Ballam L, Morris J, Sweetnam PM, Elwood PC.

Eur Heart J. 2000 Oct;21(19):1584-90.

PMID:
10988010
30.

Helicobacter pylori is an aetiological factor for ischaemic heart disease: the case in favour.

Stone AF, Mendall MA.

Dig Liver Dis. 2000 Jan-Feb;32(1):62-4. Review.

PMID:
10975757
31.

Western blotting is useful in the salivary diagnosis of Helicobacter pylori infection.

Ballam LD, Mendall MA, Asante M, Morris J, Strachan DP, Whincup PH, Cook DG.

J Clin Pathol. 2000 Apr;53(4):314-7. Erratum in: J Clin Pathol 2000 Sep;53(9):725.

32.

C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors.

Cook DG, Mendall MA, Whincup PH, Carey IM, Ballam L, Morris JE, Miller GJ, Strachan DP.

Atherosclerosis. 2000 Mar;149(1):139-50.

PMID:
10704625
33.

Relationship between Helicobacter pylori, gastric parietal cell antibodies and heat shock proteins.

Asante MA, Mendall MA, Ballam L, Morris J, Northfield TC.

Eur J Gastroenterol Hepatol. 1999 Dec;11(12):1365-70.

PMID:
10654796
34.

Chlamydia pneumoniae infection and early asymptomatic carotid atherosclerosis.

Markus HS, Sitzer M, Carrington D, Mendall MA, Steinmetz H.

Circulation. 1999 Aug 24;100(8):832-7.

PMID:
10458719
35.

Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the caerphilly prospective heart disease study.

Strachan DP, Carrington D, Mendall MA, Ballam L, Morris J, Butland BK, Sweetnam PM, Elwood PC.

BMJ. 1999 Apr 17;318(7190):1035-9.

36.

Cytomegalovirus seropositivity and incident ischaemic heart disease in the Caerphilly prospective heart disease study.

Strachan DP, Carrington D, Mendall MA, Butland BK, Sweetnam PM, Elwood PC.

Heart. 1999 Mar;81(3):248-51.

37.

Determinants of prescribing costs for ulcer-healing drugs and upper gastrointestinal endoscopy in general practice.

Asante MA, Mendall MA, Bland JM, Northfield TC.

Eur J Gastroenterol Hepatol. 1998 Jul;10(7):589-93.

PMID:
9855084
38.

Screening dyspeptic patients for Helicobacter pylori prior to endoscopy: laboratory or near-patient testing?

Asante MA, Mendall MA, Finlayson C, Ballam L, Northfield T.

Eur J Gastroenterol Hepatol. 1998 Oct;10(10):843-6.

PMID:
9831405
39.

Relation of Helicobacter pylori infection to 13-year mortality and incident ischemic heart disease in the caerphilly prospective heart disease study.

Strachan DP, Mendall MA, Carrington D, Butland BK, Yarnell JW, Sweetnam PM, Elwood PC.

Circulation. 1998 Sep 29;98(13):1286-90.

PMID:
9751676
40.

Helicobacter pylori and hepatitis A: a common route but uncommon mode of infection?

Sundaram KK, Mendall MA.

Helicobacter. 1998 Jun;3(2):140-1. No abstract available.

PMID:
9631315
41.

Clinical practice--strategies for management of dyspepsia.

Zar S, Mendall MA.

Br Med Bull. 1998;54(1):217-28. Review.

PMID:
9604445
42.

Which Helicobacter pylori-positive dyspeptics are likely to respond symptomatically to empirical H. pylori eradication?

Asante MA, Mendall MA, Northfield TC.

Eur J Gastroenterol Hepatol. 1998 Mar;10(3):265-8.

PMID:
9585033
43.

Inflammatory responses and coronary heart disease.

Mendall MA.

BMJ. 1998 Mar 28;316(7136):953-4. No abstract available.

44.

C-reactive protein response and progression of atherosclerosis: is atherosclerosis the byproduct of systemic infection?

Mendall MA.

Cardiologia. 1997 Nov;42(11):1139-44. Review. No abstract available.

PMID:
9534305
45.

Antibiotic use, childhood affluence and irritable bowel syndrome (IBS).

Mendall MA, Kumar D.

Eur J Gastroenterol Hepatol. 1998 Jan;10(1):59-62.

PMID:
9512954
46.
47.

Hyperhomocysteinaemia, Helicobacter pylori, and coronary heart disease.

Whincup PH, Mendall MA, Perry IJ, Strachan DP.

Heart. 1997 Nov;78(5):524. No abstract available.

48.

Irritable bowel syndrome.

Maxwell PR, Mendall MA, Kumar D.

Lancet. 1997 Dec 6;350(9092):1691-5. Review. No abstract available.

PMID:
9400529
49.

Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease.

Mendall MA, Patel P, Asante M, Ballam L, Morris J, Strachan DP, Camm AJ, Northfield TC.

Heart. 1997 Sep;78(3):273-7.

50.

Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction.

Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ.

Circulation. 1997 Jul 15;96(2):404-7.

PMID:
9244203

Supplemental Content

Loading ...
Support Center